Related Experiment Video
Updated: Apr 19, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Systemic AA amyloidosis as a prion-like disorder
Tomoaki Murakami1, Yasuo Inoshima2, Naotaka Ishiguro2
1Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Tokyo, Japan.
AA amyloidosis, a lethal protein misfolding disease, can be experimentally induced and transmitted between animals. This review examines the pathology and transmission mechanisms of AA amyloidosis, highlighting its seeding-nucleation process similar to prion diseases.
Area of Science:
- Veterinary Pathology
- Protein Misfolding Diseases
- Immunology
Background:
- Amyloidosis encompasses disorders caused by misfolded protein accumulation (amyloid) in beta-sheets, leading to organ dysfunction.
- AA amyloidosis, a fatal systemic form, involves serum amyloid A (SAA) protein and affects multiple animal species.
- Experimental models demonstrate that inflammatory stimuli can induce AA amyloidosis.
Purpose of the Study:
- To review the pathology of AA amyloidosis in animals.
- To examine the transmissibility of AA amyloidosis across species.
- To elucidate the mechanisms underlying AA amyloidosis transmission.
Main Methods:
- Review of existing literature on AA amyloidosis pathology and experimental induction.
- Analysis of studies investigating the transmission of AA amyloidosis.
- Comparison of AA amyloidosis transmission with prion disease mechanisms.
Main Results:
- AA amyloidosis can be experimentally induced by sustained inflammatory stimuli in animal models.
- Administration of pre-formed AA amyloid accelerates disease development, a phenomenon termed transmission.
- Transmission is proposed to occur via a seeding-nucleation process, analogous to prion propagation.
Conclusions:
- AA amyloidosis exhibits transmissibility, influenced by seeding-nucleation mechanisms.
- Understanding transmission is crucial for managing and preventing AA amyloidosis in susceptible animal populations.
- Further research into the molecular basis of AA amyloidosis transmission can inform therapeutic strategies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Subviral Agents
Alzheimer Disease l: Introduction

